Apomorphine (APO-go & Dacepton)
- BNF:
- 4.9.1
- Status:
- Amber
- Decision Date:
- December 2019
Comments
See shared care guideline for Parkinson's disease
Amber Drug Classifications
- 1: Requiring specialist assessment to enable patient selection and initiation of treatment
search again